Celaid Therapeutics is pleased to announce that we won first place in the 10th Health and Medical Venture Grand Prize – Drug Discovery & SaMD League, hosted by Keio University School of Medicine, on October 19, 2025.
Following this achievement, our CEO, Nobuyuki Arakawa, will take the stage at the final judging session of the Health and Medical Venture Grand Prize on December 21, where he will deliver a presentation on our innovative technology for the ex vivo expansion of hematopoietic stem cells, enabling advances in cell and gene therapy development.
